Journals / Cardiovascular surgery and interventions / 2022 / Cilt: 9 - Sayı: 1

Early clinical results of surgical treatment of active infective endocarditis

Pages
27–35
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Our study results suggest that active IE is associated with high mortality rates.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: In this study, we present early results of surgery in patients who were surgically treated for active infective endocarditis (IE).
📊
Key Findings & Data:Patients and methods: Between October 2015 and June 2020, a total of 28 patients (21 males, 7 females; mean age: 62±9 years; range: 46 to 78 years) with an active IE who were not previously operated were retrospectively analyzed.
💡
Conclusion & Impact:Conclusion: Our study results suggest that active IE is associated with high mortality rates.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: In this study, we present early results of surgery in patients who were surgically treated for active infective endocarditis (IE). Patients and methods: Between October 2015 and June 2020, a total of 28 patients (21 males, 7 females; mean age: 62±9 years; range: 46 to 78 years) with an active IE who were not previously operated were retrospectively analyzed. The diagnosis of IE was made on the basis of clinical and transthoracic echocardiographic findings, and microbiological growth in the blood culture. The patients were divided into two groups according to the type of surgery [Group 1 (valve replacement group; n=21) and Group 2 (valve repair; n=7)]. Baseline and operative data of the patients were compared. Results: The median follow-up was 3.4 (range: 2-5 yeras) years. Blood cultures were positive in 19 (67.8%) patients. Coagulase-negative Staphylococci, Staphylococcus epidermidis, and methicillin-resistant Staphylococcus aureus were the most common microorganisms. The main symptoms were fever, fatigue, shortening of breath, and dyspnea. We performed an urgent surgery in six patients who had congestive heart failure resistant to medical treatment (n=2) and pulmonary embolic events (n=4). If there were perivalvular abscess formation, and multiloculated mobile and large vegetations in patients with sepsis or hemodynamic instability despite intense medical treatment including inotropic administration, we preferred early surgery. The postoperative mortality rate was 10.7%. Conclusion: Our study results suggest that active IE is associated with high mortality rates. Valve repair may be chosen in eligible patients after the extensive resection of infected leaflets with acceptable results

🔖

Cite This Article

Azboy, D., Temiztürk, Z. (2022). Early clinical results of surgical treatment of active infective endocarditis. Cardiovascular surgery and interventions, Cilt: 9 - Sayı: 1, 27–35. https://ajindex.com/articles/470969

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Hoen B, Alla F, Selton-Suty C, Béguinot I, Bouvet A, Briançon S, et al. Changing profile of infective endocarditis: Results of a 1-year survey in France. JAMA 2002;288:75-81
  2. Cabell CH, Abrutyn E. Progress toward a global understanding of infective endocarditis. Lessons from the International Collaboration on Endocarditis. Cardiol Clin 2003;21:147-58
  3. Miró JM, del Río A, Mestres CA. Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients. Cardiol Clin 2003;21:167-84
  4. Musci M, Siniawski H, Pasic M, Grauhan O, Weng Y, Meyer R, et al. Surgical treatment of right-sided active infective endocarditis with or without involvement of the left heart: 20-year single center experience. Eur J Cardiothorac Surg 2007;32:118-25
  5. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N Engl J Med 2001;345:1318-30
  6. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults: Diagnosis, antimicrobial therapy, and management of complications: A scientific statement for healthcare professionals from the American Heart Association. Circulation 2015;132:1435-86
  7. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015;36:3075-128
  8. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons, Bonow RO, Carabello BA, Kanu C, de Leon AC Jr, Faxon DP, Freed MD, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): Developed in collaboration with the Society of Cardiovascular Anesthesiologists: Endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006;114:e84-231
  9. Kocogullari-Uğur C, Karpuzoğlu E, Kısa U. Treatment of infective endocarditis. In: Dike